Allergy and Immunogenicity Revisited
After the pause in answering the Rare Disease Day video questions to consolidate them into the aHUS Patients Research Agenda; and…
After the pause in answering the Rare Disease Day video questions to consolidate them into the aHUS Patients Research Agenda; and…
While beginning to give responses to the questions featuring in the Rare Disease Day Video, the alliance has also been collating…
There are three questions in the Rare Diseases Day video which ask about allergy and immunity to eculizumab. These may be…
A couple of questions in the Rare Diseases Day video are about something that aHUS folk often talk about whenever they…
Questions relating to alternatives to eculizumab for aHUS ,and where those developments were up to, featured within many questions about eculizumab…
It’s difficult for rare disease patients to find information about their condition and even more so for patients with medical…
Two questions in the Rare Disease Day video address the same issue but from different perspectives. Pepe of Madrid Spain…
Article No. 4 March 2017 ( See also article on affordability of Ravulizumab at this LINK ) Severine of…
A question which featured a number of times in the Rare Disease Day video was about access to complement inhibitors for…